• Journal of Pharmaceutical Investigation
• /
• 제31권2호
• /
• pp.73-80
• /
• 2001

Lung perfusion scanning, invariably combined with ventilation studies provides a reliable and non-invasive mean to diagnose lung related pathologies despite the availability of modern techniques such as angiography, magnetic resonance imaging, magnetic resonance angiography, and helical (spiral) computed tomography. The technique involves the generation of images by radiations emitted from radioisotopes introduced in to the lungs. Various radiopharmaceuticals have been proposed and designed to incorporate $Tc^{99m}$ in to macroparticulate form for lung perfusion imaging. However, most of these have associated difficulties such as reproducibility of the product with regards to particle size distribution and poor elimination from the lung capillary bed. $Tc^{99m}$ macroaggregated albumin $(Tc^{99m}-MAA)$ is used extensively for clinical lung perfusion imaging and is considered as the radiopharmaceutical of choice. It is non-toxic, safe, and being biodegradable, is easily eliminated from the lung capillary bed by proteolytic enzyme metabolism and by mechanical forces due to lung movement.

• 방사성폐기물학회지
• /
• 제6권1호
• /
• pp.11-15
• /
• 2008

고밀도폴리 에틸렌 고건전성용기에 담은 폐수지의 운반을 위해 원전 폐수지의 방사능 분석결과를 사용하여 운반물 등급 분류방법을 도출하였다. 원전 폐수지의 방사능 분석결과로부터 폐수지 내 핵종 존재비를 구하였고, 폐수지의 표면선량률로 핵종재고량을 평가하기 위해 MCNP 코드로 방사능대선량 환산인자를 모사하였다. 이로부터 고밀도폴리에틸렌 고건전성용기에 담은 폐수지에 대한 A형 운반물과 B형 운반물의 경계값은 1.19 TBq 이고 이를 표면선량으로 환산한 결과는 124.2 mSv/h임을 알 수 있었다.

• 분석과학
• /
• 제10권5호
• /
• pp.307-314
• /
• 1997

지질시료 중의 U과 Th을 유도결합플라즈마 원자방출분광법으로 정량하기 위해 시료를 혼산으로 분해하고 TTA(thenoyltrifluoroacetone)와 TOA (tri-n-octylamine) 추출제를 이용하여 계통적으로 용매추출한 다음 HCl 용액으로 역추출하여 분리하였다. 표준암석 NIST SRM 278에 대한 분석결과는 NIST 및 다른 비파괴분석 결과와 비교하여 양호하였다. 알파선분광법으로 U과 Th의 자연방사성 동위원소를 측정하기 위해 추출분리한 각각을 음이온교환크로마토그래피로 정제하였다.

• 한국방사성폐기물학회:학술대회논문집
• /
• 한국방사성폐기물학회 2004년도 Proceedings of the 4th Korea-China Joint Workshop on Nuclear Waste Management
• /
• pp.12-27
• /
• 2004

Pretreatment process consisted of submerged hollow-fiber microfiltration(HMF) membrane and spiral-wound nanofiltration(SNF) membrane has been developed by NETEC, KHNP for the purpose of improving the impurities of liquid radioactive waste before entering Selective Ion Exchange System(SIES). The lab-scale combined system was installed at Kori NPP #2 nuclear power plant and demonstration tests using actual liquid radioactive waste were carried out to verify the performance of the combined system. The submerged HMF membrane was adopted for removal of suspended solid in liquid radioactive waste and the SNF membrane was used for removal of particulate radioisotope such as, Ag-l10m and oily waste because ion exchange resin can not remove particulate radioisotopes. The liquid waste in Waste Holdup Tank (WHT) was processed with HMF and SNF membrane, and SIES. The initial SS concentration and total activity of actual waste were 38,000ppb and $1.534{\times}10_{-3}{\mu}Ci/cc$, respectively. The SS concentration and total activity of permeate were 30ppb and lower than LLD(Lower Limit of Detection), respectively.

• 대한임상독성학회지
• /
• 제9권2호
• /
• pp.39-48
• /
• 2011

In mass casualty situation due to radiological accidents, it is important to start aggressive management with rapid triage decisions. External contamination needs immediate decontamination and internal contamination should be treated with special expertise and equipment to prevent the rapid uptake of radionuclides by target organs. Acute radiation syndrome shows a sequence of events that varies with the severity of the exposure. More severe exposures generally lead to more rapid onset of symptoms and severe clinical findings. After the massive exposure, various systems of the body reflect their severe damages that can lead to death within hours or up to several months. The disease progression has classically been divided into four stages: prodromal, latent, manifest illness, and recovery or death. Three characteristic clusters of symptoms including the hematopoietic syndrome, the gastrointestinal syndrome and the cerebrovascular syndrome are all associated with the acute radiation syndrome. The standard medical management of the patients with a potentially survivable radiation exposure includes good medical, surgical and supportive measures. Specific treatment with cytokines and bone marrow transplantation should be considered. The management of internal contamination is much the same as the treatment of poisoning. The standard decontamination should be applied to reduce uptake, and the chelating agents can be administered to enhance the clearance of radioisotopes. Radioactive iodine ($^{131}I$) as one of the nuclear fission products can increase the incidence of thyroid cancer in children. Potential benefit of potassium iodide prophylaxis is greater especially in neonates, infants and small children.

• 대한방사성의약품학회지
• /
• 제6권1호
• /
• pp.53-58
• /
• 2020

Pretargeting is a two-component strategy often used for tumor targeting to enhance the tumor-to-background ratio in cancer diagnosis as well as therapy. In the multistep strategy, the highly specific unlabeled monoclonal antibodies (mAbs) with the reactive site is allowed to get localized at tumor site first, and then small and fastclearing radiolabeled chelator with counter reactive site is administered which covalently attaches to mAbs via inverse electron demand Diels-Alder reaction (IEDDA). The catalyst-free IEDDA cycloaddition reaction between 1,2,4,5-tetrazines and strained alkene dienophiles aid with properties like selective bioconjugation, swift and high yielding bioorthogonal reactions are emergent in the development of radiopharmaceutical. Due to its fast pharmacokinetics, the in vivo formed radioimmunoconjugates can be imaged at earlier time points by short-lived radionuclides like ¹⁸F and ⁶⁸Ga; it can also reduce radiation damage to the normal cells. Ultimately, this review elucidates the updated status of pretargeting based on antibodies and IEDDA for tumor diagnosis (PET and SPECT) and therapy.

• 전자공학회논문지 IE
• /
• 제45권2호
• /
• pp.6-12
• /
• 2008

본 연구에서는 아스팔트 함량의 중요성을 인식하여 현재 법적 규제 면제치인 100[${\mu}Ci$]이하의 방사성 동위원소를 이용한 아스팔트 함량측정기의 개발을 목표로 하였다. 이를 위하여 중성자선원의 위치에 따라 아스팔트 함량에 변화를 주는 3가지의 분야로 나누었다. 먼저, 아스팔트 혼합물과 중성자 선원과의 간격을 줄일 경우, 반사체 설치의 경우, 이력수를 변화시켰을 경우로 나누어서 컴퓨터 시뮬레이션을 통하여 살펴보았으며, 만족스러운 오차범위 결과를 얻어 아스팔트 함량측정기기의 개발을 위한 설계 자료로 활용하고자하였다.

• Nuclear Engineering and Technology
• /
• 제48권3호
• /
• pp.597-607
• /
• 2016

Personalized medicine is tailored medical treatment that targets the individual characteristics of each patient. Theragnosis, combining diagnosis and therapy, plays an important role in selecting appropriate patients. Noninvasive in vivo imaging can trace small molecules, antibodies, peptides, nanoparticles, and cells in the body. Recently, imaging methods have been able to reveal molecular events in cells and tissues. Molecular imaging is useful not only for clinical studies but also for developing new drugs and new treatment modalities. Preclinical and early clinical molecular imaging shows biodistribution, pharmacokinetics, mechanisms of action, and efficacy. When therapeutic materials are labeled using radioisotopes, nuclear imaging with positron emission tomography or gamma camera can be used to treat diseases and monitor therapy simultaneously. Such nuclear medicine technology is defined as radiation theragnosis. We review the current development of drugs and technology for radiation theragnosis using peptides, albumin, nanoparticles, and cells.

• 공업화학
• /
• 제28권2호
• /
• pp.141-152
• /
• 2017

1,2,4,5-테트라진 유도체를 이용한 inverse electron-demand Diels-Alder (IEDDA) 반응은 다양한 생체물질, 고분자, 나노 물질 복합체의 효율적인 합성에 폭넓게 활용되고 있다. IEDDA는 유기용매에서뿐만 아니라 생리학적 조건 하에서도 매우 특이적이며 빠른 반응속도를 가지고 있는 것으로 알려져 있다. 이러한 특성으로 인해 본 반응은 다양한 생물학적 활성을 가지는 물질의 방사성동위원소 표지와 분자영상 및 질병 치료를 위한 방사성의약품 개발에도 활발히 응용되고 있다. 본 리뷰 논문은 IEDDA 반응을 방사화학 및 핵의학 분야에서 이용한 최근 연구 동향 및 연구 결과 그리고 향후 전망에 대해 소개하고자 한다.

• 대한전기학회:학술대회논문집
• /
• 대한전기학회 1997년도 추계학술대회 논문집 학회본부
• /
• pp.357-360
• /
• 1997

Currently, there is a need for the development of an advanced new technology for Low-and Intermediate-Level Radioactive Waste (LILW) treatment from nuclear power plants. The vitrification and melting technology by the use of the electrical equipments such as induction heater and plasma torch based furnace, along with off-gas treatment are considered as the most promising one of the LILW treatment technology since they can produce a very stable waste forms as well as considerably large volume reduction, which is a world-wide trend to apply for radioactive waste treatment. Korea Electric Power Research Institute(KEPRI) has already completed a feasibility study on LILW treatment and conceptual system design of a demonstration plant to be constructed. For this research, KEPRI selected a cold crucible melter(CCM) for the vitrification of combustible waste, and plasma torch based furnace(PT) for the melting of noncombustible waste, along with off-gas treatment for the volatile radioisotopes such as cesium.